. . . . . . . "[In this study we investigated the crosstalk among NRF2, AHR and ER? in MCF-7 breast cancer cells treated with the NRF2 activator sulforaphane (SFN), a dual AHR and ER? activator, 3,3'-diindolylmethane (DIM), 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) or 17?-estradiol (E2).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:12:53+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .